500 likes | 637 Views
Situation Analysis of Cervical Cancer Screening in Thailand Progress Report on Quantitative Analysis. IHPP June 8, 2007. An Optimal Policy Strategy for Prevention and Control of Cervical Cancer in Thailand Proposed by International Health Policy Program Funded by World Bank.
E N D
Situation Analysis of Cervical Cancer Screening in ThailandProgress Report on Quantitative Analysis IHPP June 8, 2007
An Optimal Policy Strategy for Prevention and Control of Cervical Cancer in Thailand Proposed by International Health Policy Program Funded by World Bank
Study objectives • To generate reliable and relevant information to guide health policy choices about prevention and control of cervical cancer in Thailand • To recommend an optimal policy strategy that is cost-effective in the reduction of disease burden of cervical cancer. • To estimate short- and long-terms investments in human resources and infrastructure for appropriate delivery of the newly designed policy strategy for cervical cancer prevention and control.
Work Package 1 Planned Activities (Cervical Cancer Screening Program Performance)
a Pap smear model demonstration sites: Nakhon Phnom, Arng-Thong; VIA sites: Roi Et, Chiang Mai b Chiang Mai, Lampang, Songkla, Khon Kaen, Bangkok
Brief of cervical cancer screening in Thailand • Cytology screening with pap smear has been available for more than 40 years • In 1997, MOPH began to offer reproductive health services in conjunction with family planning. National policy for cervical cancer proposed that screening be offered to women aged 35–54 years with a Pap test every five years and, in the northeast of Thailand, using visual inspection methods.
Brief of cervical cancer screening in Thailand • 13.5% of the female aged 35-59 years have not been screened for cervical cancer during the last 5 year period. • 36.7% have never been screened for their lifetimes. • Only 49.8% exposed to the screening service at least once within the interval of 5 years. (NSO, 2006) • 37.7% of the female aged 15-44 yearsin 2005 by Reproductive Health Division.
Brief of cervical cancer screening in Thailand • The national program target set by National Health Security Office (NHSO) and MOPH for cervical cancer screening in 2005. • 0.70 million (or 34% of the target group), divided 0.60 million for Pap smear and 0.10 million for VIA are the target group.
Visual inspection with acetic acid Cryotherapy unit VIA positive
Data system: PapRegistry Collect sample PHO Slide reading NCI NHSO Colposcopy or refer
Data System: CPIS PHO VIA DHO Colposcopy or refer NHSO
Situation analysis for coverage and program outcome in selected area • Pap smear : demonstration site of NCI (Nakhon Phanom) • VIA : one oldest site (Roi Et, started 2000) and one other newly implemented site (Chiang Mai, started 2005)
PapRegistry • N = 472,694 • Chiangmai = 11,901 • Smear_hcode, province, pid, age, read_hcode, finding, adequacy CPIS • N = 307,442 (18 provinces) • Chiangmai = 28,737 • VIA, cryo, refer, suspca, VIA-pap
Definition of coverage • Coverage 1 = No. target cases / No. target population • Coverage 2 = No. new cases in 5 y / No. target population • Coverage 3 = No. new cases in 5 y regardless of the screen type / No. target population
Proportion of case % 90.0% 88.1% 88.2%
Screendate distribution (PapReg) Chiang Mai
Screening Visits, Chiang Mai No. of visit 99.6% 99.9% 98.7%
Screening Cases No. of case 90.1% 97.3% 79.2%
Classified screen – Append file • screen "via" if via result =1 or 2 • screen "pap" if via result are blank and papdate indicate(via-pap) • 6,147/28,731 = 21.4% conducted the via-pap group. • 79.76% not completely the SCJ to determine
Trend over time % coverage
Roi Et, VIA started 2000 Case Coverage in % 10.41 11.06 9.06 8.39 6.50 3.45 VIA started NHSO involved
Facility Performance (Pap smear) 3.35 3.40 36.87 56.11 1.48 1.37 42.32 54.45 2005 2006
Facility Performance (VIA) 6.81 15.91 92.92 2005 84.09 2006